AcuCort publishes September 2026 newsletter

Pharmaceutical company AcuCort has released its newsletter for September 2026.

The publication focuses on scientific papers concerning Zeqmelit®, AcuCort's medicinal product. The company emphasizes that scientific publications are crucial for its ongoing development and international expansion efforts.

Within the newsletter, AcuCort details how scientific evidence supports the use and market standing of Zeqmelit®. The company views a strong scientific foundation as essential for continued growth and entry into new markets.

Further information regarding Zeqmelit® and AcuCort's strategic direction is available through the company's official channels and directly from its leadership. AcuCort aims to enhance awareness of its products and their scientific basis among industry professionals and patients.